Detailed information for compound 1552763

Basic information

Technical information
  • TDR Targets ID: 1552763
  • Name: 4-methyl-N'-[2-[[5-phenyl-4-(phenylmethyl)-1, 2,4-triazol-3-yl]sulfanyl]acetyl]benzohydrazi de
  • MW: 457.547 | Formula: C25H23N5O2S
  • H donors: 2 H acceptors: 4 LogP: 4.4 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(CSc1nnc(n1Cc1ccccc1)c1ccccc1)NNC(=O)c1ccc(cc1)C
  • InChi: 1S/C25H23N5O2S/c1-18-12-14-21(15-13-18)24(32)28-26-22(31)17-33-25-29-27-23(20-10-6-3-7-11-20)30(25)16-19-8-4-2-5-9-19/h2-15H,16-17H2,1H3,(H,26,31)(H,28,32)
  • InChiKey: WZCZYJLASLVTGU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-methyl-N'-[1-oxo-2-[[5-phenyl-4-(phenylmethyl)-1,2,4-triazol-3-yl]thio]ethyl]benzohydrazide
  • N'-[2-[[4-(benzyl)-5-phenyl-1,2,4-triazol-3-yl]thio]acetyl]-4-methyl-benzohydrazide
  • 4-methyl-N'-[2-[[5-phenyl-4-(phenylmethyl)-1,2,4-triazol-3-yl]sulfanyl]ethanoyl]benzohydrazide
  • 4-Methyl-benzoic acid N'-[2-(4-benzyl-5-phenyl-4H-[1,2,4]triazol-3-ylsulfanyl)-acetyl]-hydrazide
  • MLS000552932
  • SMR000177680
  • BAS 02750700

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus dipeptidyl aminopeptidaseprotein 0.2378 1 1
Trypanosoma brucei serine peptidase, Clan SC, Family S9B 0.1021 0.3028 0.0831
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.2057 0.835 0.7634
Loa Loa (eye worm) hypothetical protein 0.0589 0.0806 0.0806
Toxoplasma gondii prolyl endopeptidase 0.2057 0.835 1
Trypanosoma brucei prolyl endopeptidase 0.2057 0.835 1
Mycobacterium ulcerans protease II (oligopeptidase B), PtrB 0.0927 0.2545 0.5
Trypanosoma cruzi dipeptidyl-peptidase 8-like serine peptidase 0.1021 0.3028 0.0831
Brugia malayi prolyl oligopeptidase family protein 0.2057 0.835 0.8206
Onchocerca volvulus Dipeptidyl peptidase family member 1 homolog 0.2378 1 1
Mycobacterium leprae PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) 0.0927 0.2545 0.5
Schistosoma mansoni subfamily S9B unassigned peptidase (S09 family) 0.2378 1 1
Brugia malayi prolyl oligopeptidase family protein 0.1021 0.3028 0.2417
Trypanosoma brucei Dipeptidyl-peptidase 8-like, putative 0.1021 0.3028 0.0831
Trypanosoma cruzi serine peptidase, Clan SC, Family S9B 0.1021 0.3028 0.0831
Echinococcus multilocularis dipeptidyl aminopeptidaseprotein 0.2378 1 1
Echinococcus granulosus prolyl endopeptidase 0.2057 0.835 0.7634
Loa Loa (eye worm) prolyl oligopeptidase 0.2378 1 1
Schistosoma mansoni prolyl oligopeptidase (S09 family) 0.2057 0.835 0.7634
Loa Loa (eye worm) hypothetical protein 0.2057 0.835 0.835
Leishmania major prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative 0.2057 0.835 1
Echinococcus multilocularis prolyl endopeptidase 0.2057 0.835 0.7634
Trypanosoma cruzi prolyl endopeptidase 0.2057 0.835 1
Mycobacterium tuberculosis Probable protease II PtrBa [first part] (oligopeptidase B) 0.1678 0.6406 1
Leishmania major dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B 0.1021 0.3028 0.0831

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) > 80 uM PubChem BioAssay. Dose response counterscreen for EBI2 assay utilizing the enzyme, b-galactosidase. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 3.5481 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 100 uM PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.